Currently, there are no established treatment guidelines for clinical vasospasm following subarachnoid
hemorrhage (CV). Intra-arterial nimodipine injection (IAN) is gaining popularity as a treatment option. As a
result, the author has gathered data on the outcomes of this method and proposes a suitable management
protocol.